Betting on Prevention Over Treatment

Saudi Arabia-based healthtech startup Madeed has raised additional pre-seed funding, bringing its total capital raised to $925,000 as it works to build a preventive healthcare platform focused on early disease detection. The latest round includes participation from SEEDRA Ventures, Unity Investment Partners, and Seen Growth, alongside earlier investors such as Vision Ventures and a group of Saudi angel investors.

Founded in 2025 by Adam Bataineh, Madeed is positioning itself at the intersection of healthcare, data, and artificial intelligence. The company is focused on shifting healthcare from a reactive model to a proactive one by identifying disease risks before symptoms appear.

The new funding will be used to accelerate product development and expand clinical and laboratory partnerships, with an initial focus on scaling within Saudi Arabia.

A Shift Toward Early Detection and Longevity

Healthcare systems globally have traditionally focused on treatment after diagnosis. Madeed is built on a different premise. The company is developing a platform that leverages advanced biomarkers, laboratory testing, and artificial intelligence to detect early risk indicators across hundreds of potential conditions.

By analyzing detailed health data, the platform aims to provide personalized insights, enabling individuals to take preventive action well before disease onset. This approach aligns with a growing global emphasis on longevity and lifestyle-driven health optimization.

Madeed also plans to deliver tailored health recommendations, personalized nutrition plans, and targeted supplements, all designed to help users maintain long-term health in a structured and sustainable way.

Early Traction Signals Market Demand

Before its broader launch, Madeed has already begun testing its platform through a pilot phase. During this period, the company attracted 150 subscribers, providing early validation of demand for preventive and personalized healthcare services in the region.

Founder and CEO Dr. Adam Bataineh highlighted the importance of this early traction, noting that the results reflect a growing awareness around proactive health management and the need for solutions that go beyond traditional care models.

He emphasized that the company has focused on ensuring operational readiness, smooth system integration, and service reliability before scaling further.

Building an Ecosystem of Clinical Partnerships

A key component of Madeed’s strategy is building strong partnerships with clinical and laboratory providers. These collaborations are essential for delivering accurate diagnostics and ensuring the reliability of health insights generated by the platform.

By integrating with healthcare infrastructure, Madeed aims to create a seamless experience where users can access testing, receive insights, and act on recommendations within a unified system.

This ecosystem-driven approach positions the company as more than a standalone application. It becomes part of a broader healthcare network designed to support preventive care at scale.

Investor Backing Signals Confidence in Preventive Health

The investor group backing Madeed reflects growing interest in healthcare innovation across the region. Firms such as SEEDRA Ventures, Unity Investment Partners, and Seen Growth have been actively supporting early-stage startups focused on long-term impact and technological advancement.

Their participation signals confidence in both the team and the broader opportunity in preventive healthcare, a space that is gaining traction as populations become more health-conscious and systems shift toward efficiency and cost reduction.

Earlier backing from Vision Ventures and Saudi angel investors further reinforces the belief that Madeed is addressing a critical gap in the healthcare landscape.

Building the Future of Healthcare in Saudi Arabia

Madeed’s emergence aligns with Saudi Arabia’s broader push toward innovation in healthcare as part of its Vision 2030 agenda. As the Kingdom invests in digital health infrastructure and advanced medical technologies, platforms that focus on prevention and personalization are becoming increasingly relevant.

By combining laboratory data, artificial intelligence, and personalized health planning, Madeed is positioning itself as a new layer in the healthcare system, one that prioritizes early intervention and long-term well-being.

Redefining How Health Is Managed

The company’s long-term vision extends beyond diagnostics. It aims to redefine how individuals engage with their health by providing continuous, data-driven insights rather than episodic care.

If successful, this model could reduce the burden on healthcare systems, improve quality of life, and shift the focus from managing illness to maintaining health.

For Madeed, the goal is clear. Move healthcare upstream, where risks are identified early and action is taken before conditions develop.

In doing so, the company is not just building a product. It is contributing to a broader shift in how health is understood and managed in the region.

Mohammed Abubakr

Mohammed Abubakr is the Founder & Editor of StartupMuslim.com. Through StartupMuslim, he documents the journeys of Muslim founders across industries, focusing on the challenges they overcome, the vision that drives them, and the impact they create.His work centers on building a narrative layer for the global Muslim startup ecosystem—one that not only highlights success, but also captures the process, discipline, and values behind it. By conducting in-depth interviews and publishing founder stories, he aims to inspire and enable the next generation of Muslim entrepreneurs to think bigger and build with purpose.